Quick answer
BridgeBio Pharma, Inc. (BBIO) reported diluted EPS of $-0.78 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-10. Its last four 10-Q/10-K filings were on 2026-08-10, 2026-05-07, 2026-02-24, 2025-10-29.
Data as of 2026-08-10. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-08-10 | $-0.78 |
| 2026-03-31 | Quarter | 10-Q | 2026-05-07 | $-0.84 |
| 2025-12-31 | Full year | 10-K | 2026-02-24 | $-3.78 |
| 2025-09-30 | Quarter | 10-Q | 2025-10-29 | $-0.95 |
| 2025-06-30 | Quarter | 10-Q | 2025-08-05 | $-0.95 |
| 2025-03-31 | Quarter | 10-Q | 2025-04-29 | $-0.88 |
| 2024-12-31 | Full year | 10-K | 2025-02-20 | $-2.88 |
| 2024-09-30 | Quarter | 10-Q | 2024-11-12 | $-0.86 |
| 2024-06-30 | Quarter | 10-Q | 2024-08-01 | $-0.39 |
| 2024-03-31 | Quarter | 10-Q | 2024-05-02 | $-0.20 |
| 2023-12-31 | Full year | 10-K | 2024-02-22 | $-3.95 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-02 | $-1.08 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-03 | $-0.98 |
| 2023-03-31 | Quarter | 10-Q | 2023-05-04 | $-0.92 |
| 2022-12-31 | Full year | 10-K | 2023-02-23 | $-3.26 |
| 2022-09-30 | Quarter | 10-Q | 2022-11-03 | $-0.93 |
Related
- BAH earnings report dates and EPS history (Booz Allen Hamilton Holding Corporation)
- BALL earnings report dates and EPS history (Ball Corporation)
- BAX earnings report dates and EPS history (Baxter International Inc.)
- BBY earnings report dates and EPS history (Best Buy Co., Inc.)
- BDX earnings report dates and EPS history (Becton, Dickinson And Company)
- BE earnings report dates and EPS history (Bloom Energy Corporation)
- BEN earnings report dates and EPS history (Franklin Resources Inc)
- BF-B earnings report dates and EPS history (Brown Forman Corp)
Last updated 2026-10-16. Data only, not financial or tax advice.